Statistics
Publications
5
Citations
290
H-Index
5
Active since
2013
Hanzhi Cui is an author at Chinese PLA General Hospital specializing in oncology, medicine, and epithelial-mesenchymal transition markers.
Publications per year
2013–2020
5
5
MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3
Zhongyi Fan, Hanzhi Cui, Xiaojie Xu et al. · Oncotarget · 2015 · 150 citations · Full text
Medicine, Cancer Biology, Oncology +15
Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway
Baiyu Han, Hanzhi Cui, Lei Kang et al. · Tumor Biology · 2015 · 98 citations
Medicine, Oncology, Pharmacology +17
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
Hanzhi Cui, Guanghai Dai, Yan Shi et al. · PubMed · 2013 · 10 citations
Medicine, Oncology, Pharmacology +15
1–5 of 5